Your browser doesn't support javascript.
loading
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes.
Pikkusaari, Sanna; Tumiati, Manuela; Virtanen, Anni; Oikkonen, Jaana; Li, Yilin; Perez-Villatoro, Fernando; Muranen, Taru; Salko, Matilda; Huhtinen, Kaisa; Kanerva, Anna; Koskela, Heidi; Tapper, Johanna; Koivisto-Korander, Riitta; Joutsiniemi, Titta; Haltia, Ulla-Maija; Lassus, Heini; Hautaniemi, Sampsa; Färkkilä, Anniina; Hynninen, Johanna; Hietanen, Sakari; Carpén, Olli; Kauppi, Liisa.
Afiliación
  • Pikkusaari S; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Tumiati M; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Virtanen A; Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.
  • Oikkonen J; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Li Y; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Perez-Villatoro F; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Muranen T; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Salko M; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Huhtinen K; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Kanerva A; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.
  • Koskela H; Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland.
  • Tapper J; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.
  • Koivisto-Korander R; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.
  • Joutsiniemi T; Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland.
  • Haltia UM; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.
  • Lassus H; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.
  • Hautaniemi S; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Färkkilä A; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Hynninen J; iCAN digital precision cancer medicine flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Hietanen S; Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland.
  • Carpén O; Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland.
  • Kauppi L; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Clin Cancer Res ; 29(16): 3110-3123, 2023 08 15.
Article en En | MEDLINE | ID: mdl-36805632
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Finlandia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Finlandia